NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-093-2003-2-US-02 Recombinant Human Metapneumovirus (HMPV) And Its Use US ORD 10/789,400 7704491 Abandoned PDF
NIAID E-093-2003-2-PCT-01 Recombinant Human Metapneumovirus (HMPV) and Its Use PCT PCT COMB PCT/US2004/005881 Expired
NIAID E-168-2003-0-PCT-02 Compositions, Methods and Kits Relating to Poxvirus Subunit Vaccine PCT PCT PCT/US2004/005903 Expired
NIMH E-247-2001-0-US-03 Effect of BDNF Genotype on Hippocampal Function and Verbal Memory And Risk For Schizophrenia US National Stage 10/789,169 Abandoned
NCI E-236-2001-0-US-03 New Adenovirus Type 7 Vectors US National Stage 10/487,974 Abandoned
NCI E-335-2001-0-US-03 Methods of Generating Human CD4+ TH1 Cells US National Stage 10/488,196 Abandoned
NIAID E-093-2003-2-IE-12 Recombinant Human Metapneumovirus (HMPV) and Its Use IE EP 04775808.1 Abandoned
NIAID E-093-2003-2-EP-03 Recombinant Human Metapneumovirus (HMPV) and Its Use EP National Stage 04775808.1 Abandoned
NIAID E-093-2003-2-CH-08 Recombinant Human Metapneumovirus (HMPV) and Its Use CH EP 04775808.1 Abandoned
NIAID E-093-2003-2-GB-11 Recombinant Human Metapneumovirus (HMPV) and Its Use GB EP 04775808.1 Abandoned
NIAID E-093-2003-2-FR-10 Recombinant Human Metapneumovirus (HMPV) and Its Use FR EP 04775808.1 Abandoned
NIAID E-093-2003-2-DE-09 Recombinant Human Metapneumovirus (HMPV) and Its Use DE EP 04775808.1 Abandoned
NIAID E-168-2003-0-US-01 The Generation and Use of Recombinant Forms of the Vaccinia Virus L1R and A33R Proteins as a Subunit Vaccine US 60/451,337 Abandoned
NCI E-094-2004-0-US-01 Pharmacodynamic Assays US 60/548,794 Abandoned
CC E-238-2003-0-US-01 Detection And Identification Of Mycobacterium Using Seca. US 60/548,371 Abandoned
NIAID E-168-2003-0-US-03 Compositions, Methods and Kits Relating to Poxvirus Subunit Vaccines US ORD 10/788,835 Abandoned
NIAID E-093-2003-2-CA-04 Recombinant Human Metapneumovirus (HMPV) and It's Use CA National Stage 2517394 Abandoned
NIAID E-168-2003-0-AU-05 Compositions, Methods and Kits Relating to Poxvirus Subunit Vaccine AU National Stage 2004262506 Abandoned
NCI E-134-2004-0-AU-03 Pharmaceutical Composition For Treatment Of Drug Dependency AU National Stage 2004216360 Abandoned
NIDCD E-168-2001-0-US-03 Transduction-1 And Transductin-2 And Applications to Hereditary Deafness US National Stage 10/487,887 7192705 Abandoned PDF
NCI E-073-2003-0-PCT-02 Protein Kinase C Inhibitor, Related Composition, and Method of Use PCT PCT PCT/US2004/05855 Expired
NCI E-134-2004-0-PCT-02 Pharmaceutical Composition For Treatment Of Drug Dependency PCT PCT PCT/JP2004/002301 Expired
NCI E-147-2003-0-US-02 Comparative Fluorimetric Hybridization Of Consensus Versus Test Sample For The Detection Of Known And Unknown Single Nucleotide Variants... US ORD 10/788,858 Abandoned
NCI E-134-2004-0-CA-04 Pharmaceutical Composition For Treatment Of Drug Dependency CA National Stage 2516618 Abandoned
NIAID E-229-2003-1-US-01 GITR Ligand And Antibodies And Uses Thereof US 60/547,975 Abandoned
NIDDK E-056-2004-0-US-01 STAMP: A Novel Factor That Augments Coactivator Activity Both In The Modulation Of GR Induction Properties And In GR Repression US 60/548,039 Abandoned
NCI E-039-2004-1-US-01 Peptide Inhibitors of Retroviral Integrase Useful for the Treatment of Retroviral Infection US 60/547,067 Abandoned
NCI E-074-2004-0-US-01 Methylation Inhibitor Compounds US 60/547,902 Abandoned
NIAID E-093-2003-2-AU-05 Recombinant Human Metapneumovirus (HMPV) and Its Use AU National Stage 2004262624 Abandoned
NCI E-137-2007-0-PCT-02 Methods For Delivering Angiogenic Modulators Using Pox Viruses PCT PCT PCT/US2004/005376 Expired
NCI E-198-2001-0-US-03 Use of a Histone Deacetylase Inhibitor to Increase The Entry of an Adenoviral Agent Into a Cell US National Stage 10/487,551 Abandoned
NIA E-204-2003-0-PCT-02 Hexahydropyrrlol [2,3-b] Indole Analogues That Alter The Processing Of Alzheimer's Disease Protein, Amyloid Precursor Protein, To Lower Amyloid-beta Peptide Levels PCT PCT PCT/US04/005391 Expired
NCI E-110-2004-0-US-01 Maleimide Anti-Tumor Phosphatase Inhibitors US 60/546,841 Abandoned
NCI E-028-2007-0-CA-06 Novel Insertion Sites In Pox Vectors CA National Stage 2515890 Expired
NCI E-028-2007-0-DE-14 Novel Insertion Sites In Pox Vectors DE EP 04817689.5 Expired
NCI E-028-2007-0-FR-15 Novel Insertion Sites In Pox Vectors FR EP 04817689.5 Expired
NCI E-028-2007-0-GB-16 Novel Insertion Sites In Pox Vectors GB EP 04817689.5 Expired
NCI E-028-2007-0-EP-07 Novel Insertion Sites In Pox Vectors EP National Stage 04817689.5 Expired
NCI E-028-2007-0-EP-10 Novel Insertion Sites In Pox Vectors EP DIV 11158563.4 Expired
NCI E-028-2007-0-GB-13 Novel Insertion Sites In Pox Vectors GB EP 11158563.4 Expired
NCI E-028-2007-0-FR-11 Novel Insertion Sites In Pox Vectors FR EP 11158563.4 Expired
NCI E-028-2007-0-DE-12 Novel Insertion Sites In Pox Vectors DE EP 11158563.4 Expired
NCI E-028-2007-0-JP-03 Novel Insertion Sites In Pox Vectors JP National Stage 2006-532294 Expired
NCI E-028-2007-0-AU-05 Novel Insertion Sites In Pox Vectors AU National Stage 2004291024 Expired
NCI E-028-2007-0-US-04 Novel Insertion Sites In Pox Vectors US National Stage 10/543,944 7638134 Expired PDF
NCI E-028-2007-0-PCT-02 Novel Insertion Sites In Pox Vectors PCT PCT PCT/US2004/005077 Expired
NCI E-087-2004-0-CA-07 Novel And Stable Pharmaceutical Formulations Of L-threo-dihydrosphingosine ("Safingol") CA National Stage 2516399 Expired
NCI E-087-2004-0-US-03 Novel And Stable Pharmaceutical Formulations Of L-threo-dihydrosphingosine ("Safingol") US National Stage 10/782,459 7476692 Issued PDF
NCI E-087-2004-0-FR-11 STABILIZED PHARMACEUTICAL COMPOSITIONS OF SAFINGOL AND METHODS OF USING THE SAME FR EP 04712898.8 Expired
NCI E-087-2004-0-DE-08 STABILIZED PHARMACEUTICAL COMPOSITIONS OF SAFINGOL AND METHODS OF USING THE SAME DE EP 04712898.8 Expired